Teva Pharmaceutical Industries Ltd. (TEVA) is poised to receive conditional clearance from the European Union for its almost $7 billion takeover of U.S. specialty drugmaker Cephalon Inc. (CEPH), Reuters reported Monday citing a person with direct knowledge of the matter.

The EU executive, which is scheduled to decide by Oct. 13 whether to clear the acquisition, wasn't immediately available for comment, Reuters said.

Full story at http://www.reuters.com/article/2011/10/10/us-cephalon-teva-eu-idUSTRE7993OH20111010

-Dow Jones Newswires; 212-416-2900

Grafico Azioni Cephalon (NASDAQ:CEPH)
Storico
Da Nov 2024 a Dic 2024 Clicca qui per i Grafici di Cephalon
Grafico Azioni Cephalon (NASDAQ:CEPH)
Storico
Da Dic 2023 a Dic 2024 Clicca qui per i Grafici di Cephalon